Cargando…

Effects of androgen deprivation therapy duration and Gleason grade on survival outcomes of high risk prostate cancer

Detalles Bibliográficos
Autores principales:	Kim, Do Kyung, Kim, Yon Hee, Kim, Jae Heon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2019
Materias:	Editorial Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798517/ https://www.ncbi.nlm.nih.gov/pubmed/35116806 http://dx.doi.org/10.21037/tcr.2019.04.05

Ejemplares similares

Androgen deprivation therapy and Gleason grade: unravelling implications on survival
por: Scott, Michael, et al.
Publicado: (2019)

Association of Prostate Cancer SLCO Gene Expression with Gleason Grade and Alterations Following Androgen Deprivation Therapy
por: Alsinnawi, Mazen, et al.
Publicado: (2019)

Commentary: Automated Diagnosis and Gleason Grading of Prostate Cancer – Are Artificial Intelligence Systems Ready for Prime Time?
por: Parwani, Anil V.
Publicado: (2019)

Exceptional pathologic complete response achieved with androgen deprivation and docetaxel therapy in Gleason 10 prostate cancer
por: Vaishampayan, Ulka, et al.
Publicado: (2019)

Biomarkers of Response to Neoadjuvant Androgen Deprivation in Localised Prostate Cancer
por: Pechlivanis, Maree, et al.
Publicado: (2021)

Differences in survival of prostate cancer Gleason 8–10 disease and the establishment of a new Gleason survival grading system
por: Zhou, Yuan, et al.
Publicado: (2020)

Duration of androgen deprivation therapy with maximum androgen blockade for localized prostate cancer
por: Fujimoto, Naohiro, et al.
Publicado: (2011)

Relationship Between Androgen Deprivation Therapy for Prostate Cancer and Risk of SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis
por: Kim, Do Kyung, et al.
Publicado: (2022)

Does brachytherapy boost improve survival outcomes in Gleason Grade Group 5 patients treated with external beam radiotherapy and androgen deprivation therapy? A systematic review and meta-analysis
por: Tang, Terence, et al.
Publicado: (2022)

Effects of statin use on the response duration to androgen deprivation therapy in metastatic prostate cancer
por: Jung, Jaeyoon, et al.
Publicado: (2015)

Effect of Androgen-Deprivation Therapy on Bone Mineral Density in Patients with Prostate Cancer: A Systematic Review and Meta-Analysis
por: Kim, Do Kyung, et al.
Publicado: (2019)

Biochemical Recurrence in Gleason Score 7 Prostate Cancer in Korean Men: Significance of the Primary Gleason Grade
por: Ro, Yun Kwan, et al.
Publicado: (2012)

Automated Gleason grading of prostate cancer tissue microarrays via deep learning
por: Arvaniti, Eirini, et al.
Publicado: (2018)

Improving survival in salivary duct cancer with adjuvant androgen deprivation therapy
por: van Boxtel, Wim, et al.
Publicado: (2019)

Socio-Economic Inequalities in Survival of Patients with Prostate Cancer: Role of Age and Gleason Grade at Diagnosis
por: Shafique, Kashif, et al.
Publicado: (2013)

Prognostic Utility of the Gleason Grading System Revisions and Histopathological Factors Beyond Gleason Grade
por: Zelic, Renata, et al.
Publicado: (2022)

Fisetin as an adjuvant treatment in prostate cancer patients receiving androgen-deprivation therapy
por: Lorenzo, Giuseppe Di, et al.
Publicado: (2022)

Living with Advanced Hormone-Sensitive Prostate Cancer and Treatment with Abiraterone and Androgen Deprivation Therapy: The Patient, Nursing and Physician Perspective
por: Collier, Tony, et al.
Publicado: (2020)

Narrative review of prostate cancer grading systems: will the Gleason scores be replaced by the Grade Groups?
por: Montironi, Rodolfo, et al.
Publicado: (2021)

Correlation of concentrations of selected trace elements with Gleason grade of prostate tissues
por: Banas, A., et al.
Publicado: (2010)

Pelvic nodal radiotherapy in Gleason grade group 5 prostate cancer
por: Cook, Kiri, et al.
Publicado: (2020)

Artificial intelligence for diagnosis and Gleason grading of prostate cancer: the PANDA challenge
por: Bulten, Wouter, et al.
Publicado: (2022)

Primary Androgen Deprivation Therapy for Prostate Cancer in Koreans: A Retrospective Multicenter Study
por: Seo, Won Ik, et al.
Publicado: (2014)

Androgen Deprivation Therapy and Cardiovascular Risk
por: Mourmouris, Panagiotis, et al.
Publicado: (2012)

Cribriform architecture outperforms Gleason pattern 4 percentage and tertiary Gleason pattern 5 in predicting the outcome of Grade Group 2 prostate cancer patients
por: Seyrek, Neslisah, et al.
Publicado: (2021)

Discrepancies on the association between androgen deprivation therapy for prostate cancer and subsequent dementia: meta-analysis and meta-regression
por: Kim, Jae Heon, et al.
Publicado: (2017)

Diet quality and Gleason grade progression among localised prostate cancer patients on active surveillance
por: Gregg, Justin R., et al.
Publicado: (2019)

Author Correction: Automated Gleason grading of prostate cancer tissue microarrays via deep learning
por: Arvaniti, Eirini, et al.
Publicado: (2019)

Author Correction: Automated Gleason grading of prostate cancer tissue microarrays via deep learning
por: Arvaniti, Eirini, et al.
Publicado: (2021)

Association between duration and type of androgen deprivation therapy and risk of diabetes in men with prostate cancer
por: Crawley, Danielle, et al.
Publicado: (2016)

Androgen deprivation and cognition in prostate cancer
por: Salminen, E, et al.
Publicado: (2003)

Treatment intensification for metastatic prostate cancer: New treatment landscapes in androgen deprivation‐based therapy
por: Turco, Fabio, et al.
Publicado: (2022)

Progression and survival in prostatic adenocarcinoma: a comparison of clinical stage, Gleason grade, S-phase fraction and DNA ploidy.
por: Vesalainen, S., et al.
Publicado: (1994)

Towards understanding androgen receptor-independent prostate cancer: an evolving paradigm
por: Zhou, Jianfu, et al.
Publicado: (2020)

Androgen Deprivation Therapy in Patients with Prostate Cancer is Associated with the Risk of Subsequent Alzheimer's Disease but Not with Vascular Dementia
por: Kim, Jong Won, et al.
Publicado: (2022)

Artificial intelligence assistance significantly improves Gleason grading of prostate biopsies by pathologists
por: Bulten, Wouter, et al.
Publicado: (2020)

Predicting prostate cancer specific-mortality with artificial intelligence-based Gleason grading
por: Wulczyn, Ellery, et al.
Publicado: (2021)

Association between Nuclear Morphometry Parameters and Gleason Grade in Patients with Prostatic Cancer
por: Malshy, Kamil, et al.
Publicado: (2022)

Prostate Cancer in Patients with Metabolic Syndrome Is Associated with Low Grade Gleason Score When Diagnosed on Biopsy
por: Jeon, Kyoung Pil, et al.
Publicado: (2012)

The curative effect of androgen deprivation therapy alone is insufficient in high-risk prostate cancer
por: Choi, Se Young, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1o43cto42b4s9efll1omcgdf26